Cauti Prevention Urology Products Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

CAUTI prevention urology products encompass the catheters, drainage and closed-system devices, antiseptic coatings, and adjunctive consumables used to lower the risk of urinary tract infections in catheterized patients. Healthcare-associated urinary infections remain among the most common device-related infections reported by government surveillance programs, which sustains steady demand for prevention-focused products across acute-care and long-term care facilities. Valued at approximately USD 6.1 billion in 2025, the market is expanding at a compound annual growth rate of about 5.4%, reflecting both higher procedure volumes and a gradual shift toward advanced antimicrobial and biofilm-resistant technologies.

• •Roughly 15-25% of hospitalized patients receive a urinary catheter during inpatient stays, creating a large baseline population for prevention products.
• •Public health agencies treat CAUTI as a key performance indicator, linking reimbursement to infection reduction in many health systems.
• •Catheter-related bloodstream and urinary infections drive measurable increases in hospital length of stay and treatment cost.

Demand is being pushed higher by aging populations with higher rates of urinary retention, diabetes, and post-surgical catheter use, all of which expand the addressable patient pool. Public payers and hospital quality programs increasingly tie reimbursement to infection-rate metrics, encouraging facilities to adopt premium closed-system catheters, antimicrobial coatings, and maintenance products. At the same time, manufacturers are introducing next-generation devices with silver, antibiotic, or nitric-oxide-releasing surfaces and biofilm-resistant polymers, which support higher average selling prices.

• •Demographic aging and rising chronic disease prevalence are increasing indwelling and intermittent catheterization rates globally.
• •Value-based purchasing and non-payment policies for preventable HAIs are accelerating premium product adoption.
• •Materials-science advances in antimicrobial and anti-adhesive catheter surfaces are reshaping clinical product portfolios.

The market segments by product type into indwelling (Foley) catheters, intermittent catheters, external catheters, and catheter maintenance and drainage accessories, with infection-prevention variants carrying price premiums across each category. End users are split primarily between hospitals, long-term care facilities, and home-care settings, where home use has been the fastest-growing segment as more patients are discharged with indwelling devices. North America holds the largest revenue share due to high procedure volumes, strong reimbursement, and early adoption of advanced coatings, followed by Europe, while Asia-Pacific is the fastest-growing region on the back of expanding hospital capacity and rising healthcare spending.

• •Indwelling Foley catheters remain the largest product category by revenue, with intermittent catheters representing a high-growth segment.
• •Hospitals account for the majority of spending, but home-care and long-term care settings are growing above the market average.
• •Asia-Pacific is the fastest-expanding region, while North America contributes the highest share of global revenue.

What are the recent trends and outlook?

The most consequential trend is the move from commodity latex and silicone catheters toward antimicrobial, anti-adhesive, and nanotechnology-enabled surfaces, with several products now in late-stage clinical and regulatory evaluation. Bundled prevention protocols that pair specific catheters with closed drainage systems, securement devices, and staff-training programs are gaining traction as hospitals pursue measurable HAI reductions. Looking ahead, the market is expected to sustain mid-single-digit growth through 2032, with above-average expansion in smart catheter sensors, biofilm-targeting coatings, and home-care prevention kits.

• •Antimicrobial and nanotechnology-based catheter coatings are moving from research settings into commercial hospital formularies.
• •Smart catheters with sensors for early infection and blockage detection are an emerging premium category.
• •Through 2032, the market is projected to reach approximately USD 9.0-9.5 billion, driven by clinical demand and product mix upgrades.